| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |